ASTRA was among the hosts and co-sponsors of a Congressional Briefing event titled, Ending Opioid Use; A New Hope, on October 11, 2018.
James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.
James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain as an alternative to opioids. Prof. Praveen Arany explained how and why PBM works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.
The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.
The panel outlined the needs for PBM adoption as:
- Research grants to fund further basic science experiments, therapeutic dose, and large multi-center clinical trials.
- FDA to create a PBM specific product code.
- Public and private health insurance reimbursement.